Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness

Over the past two decades, the three major betacoronavirus outbreaks, SARS-CoV (2002), MERS-CoV (2012), and SARS-CoV-2 (2019), have resulted in millions of infections and deaths globally. SARS-CoV-2 has displayed rapid mutations, enhancing its transmissibility, immune evasion, and resistance to existing vaccines and diagnostics. For these reasons, it has been named the most notorious viral outbreak in modern history. Due to the ever-mutating Spike (S) protein, key interactions with bioreceptors have been disrupted, making conventional detection methods more challenging. To minimize viral spread and improve diagnostic accuracy, innovative biosensing technologies are critical. As such, electrochemiluminescence (ECL) offers a powerful biosensing platform for SARS-CoV-2 variant detection by combining the high sensitivity of optical detection with electrochemistry. Its advantages include culture-independent detection, low background noise, a broad dynamic range, and the ability to detect low viral concentrations. Recent advances in multiple disciplines, such as novel luminophore development, nanotechnology, lab-on-a-chip miniaturization, and AI-driven machine learning, have further enhanced its diagnostic powers. Furthermore, smartphone-integrated ECL platforms enable rapid, point-of-care testing, improving disease surveillance and outbreak response. By uniting AI with ECL biosensing, the diagnostic system can refine variant classification and predict emerging mutations, making ECL a promising candidate for the next generation of pandemic diagnostics. Despite the many advantages, there is limited research that has explored ECL for SARS-CoV-2 variant detection, which is addressed in this review. This review highlights ECL's potential to become a gold-standard technique for detecting rapidly evolving pathogens, offering a robust and accessible solution for future infectious disease monitoring.

Authors

Institutions

Publication Details

Journal
ACS Sensors
Published
2026-11-11
DOI
https://doi.org/10.1021/acssensors.6c01907
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness

Samantha Fiona Douman, Keagan Pokpas, Kefilwe Vanessa Mokwebo, Jarid du Plooy
ACS Sensors
SARS-CoV-2 detection and testing
article

Electrochemiluminescence as a Transformative Diagnostic Tool for SARS-CoV-2 Variant Detection: Implications for Future Pandemic Preparedness

Samantha Fiona Douman, Keagan Pokpas, Kefilwe Vanessa Mokwebo, Jarid du Plooy
article en

Abstract

Over the past two decades, the three major betacoronavirus outbreaks, SARS-CoV (2002), MERS-CoV (2012), and SARS-CoV-2 (2019), have resulted in millions of infections and deaths globally. SARS-CoV-2 has displayed rapid mutations, enhancing its transmissibility, immune evasion, and resistance to existing vaccines and diagnostics. For these reasons, it has been named the most notorious viral outbreak in modern history. Due to the ever-mutating Spike (S) protein, key interactions with bioreceptors have been disrupted, making conventional detection methods more challenging. To minimize viral spread and improve diagnostic accuracy, innovative biosensing technologies are critical. As such, electrochemiluminescence (ECL) offers a powerful biosensing platform for SARS-CoV-2 variant detection by combining the high sensitivity of optical detection with electrochemistry. Its advantages include culture-independent detection, low background noise, a broad dynamic range, and the ability to detect low viral concentrations. Recent advances in multiple disciplines, such as novel luminophore development, nanotechnology, lab-on-a-chip miniaturization, and AI-driven machine learning, have further enhanced its diagnostic powers. Furthermore, smartphone-integrated ECL platforms enable rapid, point-of-care testing, improving disease surveillance and outbreak response. By uniting AI with ECL biosensing, the diagnostic system can refine variant classification and predict emerging mutations, making ECL a promising candidate for the next generation of pandemic diagnostics. Despite the many advantages, there is limited research that has explored ECL for SARS-CoV-2 variant detection, which is addressed in this review. This review highlights ECL's potential to become a gold-standard technique for detecting rapidly evolving pathogens, offering a robust and accessible solution for future infectious disease monitoring.

ACS Sensors
University of Cape Town (ZA), University of the Western Cape (ZA)
SARS-CoV-2 detection and testing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon